Lilly said retatrutide helped relieve obesity-linked conditions including knee pain, sleep apnea, and type 2 diabetes
At this time, she said pharmacies have a workaround as they play the long game
MASH develops when fat builds up in the liver, causing inflammation, scarring and cell damage, and it can progress to liver cancer, transplant or death
Treatment with 3 mg liraglutide for 20 weeks reduced appetite and energy intake, resulting in a significant weight loss (7.2 kg) in a large, RCT in people with obesity [15]
37 Future research is needed to investigate the role of GIP in inflammatory disorders and evaluate additional types of combination RAs in patients with chronic conditions associated with inflammation
This comes as the American College of Cardiology (ACC) released its five top trends in cardiovascular medicine in 2025, including Anti-Obesity Drugs: Cardiovascular Benefit Beyond Weight Loss. The ACC reports that semaglutide and tirzepatide both demonstrate remarkable cardiovascular benefits that extend beyond weight management. Clinical trials show these medications can reduce the risk of major adverse cardiovascular events by up to 20% in patients with obesity and preexisting cardiovascular conditions